Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Apyx Medical Corp (APYX)

Apyx Medical Corp (APYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Apyx Medical Corp 5115 Ulmerton Road Clearwater FL 33760 USA

www.apyxmedical.com Employees: 220 P: 727-384-2323

Sector:

Medical

Description:

Apyx Medical Corporation is an energy technology company. It provides products in the cosmetic and surgical markets. The company's Helium Plasma Technology is marketed and sold as Renuvion(R) in the cosmetic surgery market and J-Plasma(R) in the hospital surgical market. Apyx Medical Corporation, formerly known as Bovie Medical Corporation, is based in FL, United States.

Key Statistics

Overview:

Market Capitalization, $K 152,586
Enterprise Value, $K 154,736
Shares Outstanding, K 38,242
Float, K 32,429
% Float 84.80%
Short Interest, K 112
Short Float 0.29%
Days to Cover 2.13
Short Volume Ratio 0.13
% of Insider Shareholders 15.20%
% of Institutional Shareholders 55.33%

Financials:

Annual Sales, $ 48,100 K
Annual Net Income, $ -23,460 K
Last Quarter Sales, $ 12,880 K
Last Quarter Net Income, $ -1,980 K
EBIT, $ -9,500 K
EBITDA, $ -8,900 K

Growth:

1-Year Return 177.34%
3-Year Return 51.14%
5-Year Return -63.63%
5-Year Revenue Growth 70.33%
5-Year Earnings Growth -13.79%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.05 on 11/06/25
Next Earnings Date 03/12/26
Earnings Per Share ttm -0.36
EPS Growth vs. Prev Qtr 44.44%
EPS Growth vs. Prev Year 64.29%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

APYX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -151.01%
Return-on-Assets % -24.18%
Profit Margin % -48.77%
Debt/Equity 5.69
Price/Sales 3.34
Price/Cash Flow N/A
Price/Book 24.82
Book Value/Share 0.16
Interest Coverage -2.94
60-Month Beta 1.53
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar